Asian hospitals join forces to map how genetic cancer tests guide treatment
NCT ID NCT07354087
Summary
This study is a data collection project to understand how doctors in Asia use detailed genetic and molecular tests to choose follow-up treatments (like radiation or chemotherapy) for patients with endometrial cancer. It will analyze the medical records of about 300 patients treated between 2021 and 2023 from multiple hospitals. The goal is to see if using these advanced tests leads to different treatment decisions compared to using standard pathology reports alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Navi Mumbai, Maharashtra, 410210, India
-
Tata Memorial Hospital
Mumbai, Maharashtra, 400012, India
Conditions
Explore the condition pages connected to this study.